Jefferies downgraded Evotec to Hold from Buy with a price target of $3.80, down from $8.70. The firm expects Evotec’s strategic reset to take time, with “lingering uncertainty over when the market will recover.” A lack of clarity over the business trajectory in 2025 and beyond, plus risk of further delays to the strategy update, “could amplify concerns further,” the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVO:
- Evotec price target lowered to $8 from $11 at H.C. Wainwright
- Evotec AG Posts Modest Revenue Growth Amidst Cost Challenges
- Evotec price target lowered to EUR 4 from EUR 10 at Deutsche Bank
- Evotec downgraded to Sell from Hold at Deutsche Bank